Van Leeuwen & Company Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$11.8M |
| 2 |
Nice
NICE
|
+$3.43M |
| 3 |
Amphenol
APH
|
+$3.34M |
| 4 |
Apple
AAPL
|
+$2.92M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$2.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$3.54M |
| 2 |
Adobe
ADBE
|
+$3.44M |
| 3 |
Danaher
DHR
|
+$3.34M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$3.17M |
| 5 |
Intel
INTC
|
+$2.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.8% |
| 2 | Communication Services | 14.9% |
| 3 | Consumer Discretionary | 13.29% |
| 4 | Healthcare | 8.62% |
| 5 | Financials | 8.45% |
Similar funds
Van Leeuwen & Company's Q4 2020 Portfolio in Review
As of Q4 2020, Van Leeuwen & Company held 77 positions worth $149M, up 16% from $129M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Van Leeuwen & Company deployed $5.88M of net new capital in Q4 2020, opening 19 new positions and adding to 19 existing holdings. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 99,438 shares worth $12.7M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $3.17M trimmed.
- Van Leeuwen & Company's largest Q4 2020 buy was Invesco S&P 500 Equal Weight ETF: 99,438 shares worth $12.7M.
- Van Leeuwen & Company added most to Apple in Q4 2020, an estimated $2.92M increase.
- Van Leeuwen & Company's biggest Q4 2020 reduction was Bristol-Myers Squibb, cutting an estimated $3.17M.
- Van Leeuwen & Company fully exited Mondelez International in Q4 2020, selling an estimated $3.54M.
- Van Leeuwen & Company's ten largest holdings make up 43% of its $149M portfolio in Q4 2020.
- Van Leeuwen & Company opened 19 new positions and closed 12 in Q4 2020.
- Van Leeuwen & Company's portfolio value rose 16% quarter-over-quarter to $149M.
Based on Van Leeuwen & Company's 13F filing for Q4 2020, filed 16 Feb 2021.